Open AccessStage III Non–Small Cell Lung Cancer: Prognostic Value of FDG PET Quantitative Imaging Features Combined with Clinical Prognostic Factors
Author(s) -
David Fried,
Osama Mawlawi,
Lifei Zhang,
Xenia Fave,
Shouhao Zhou,
Geoffrey S. Ibbott,
Zhongxing Liao,
Laurence E. Court
Publication year - 2016
Publication title -
radiology
Language(s) - English
Resource type - Journals
eISSN - 1527-1315
pISSN - 0033-8419
DOI - 10.1148/radiol.2015142920
Subject(s) - medicine , concordance , lung cancer , positron emission tomography , stage (stratigraphy) , institutional review board , retrospective cohort study , proportional hazards model , radiology , hazard ratio , recursive partitioning , oncology , nuclear medicine , confidence interval , surgery , paleontology , biology
To determine whether quantitative imaging features from pretreatment positron emission tomography (PET) can enhance patient overall survival risk stratification beyond what can be achieved with conventional prognostic factors in patients with stage III non-small cell lung cancer (NSCLC).